A330 PREVENTION OF POST-ERCP PANCREATITIS: DO PROTEASE INHIBITORS HAVE A ROLE?

摘要

BackgroundAcute pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP). Rectal Indomethacin and prophylactic pancreatic stent placement have been shown to be effective for the prevention of post-ERCP pancreatitis. However, there remains considerable controversy regarding the usefulness of protease inhibitors (PIs) in preventing PEP.